Allen Investment Management LLC cut its stake in Monsanto Co. (NYSE:MON) by 2.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 425,027 shares of the company’s stock after selling 12,383 shares during the period. Monsanto accounts for approximately 3.4% of Allen Investment Management LLC’s portfolio, making the stock its 11th largest position. Allen Investment Management LLC owned approximately 0.10% of Monsanto worth $43,952,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. WFG Advisors LP increased its position in Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares in the last quarter. Signaturefd LLC increased its position in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares in the last quarter. Mycio Wealth Partners LLC increased its position in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares in the last quarter. Enterprise Financial Services Corp increased its position in Monsanto by 4.5% in the second quarter. Enterprise Financial Services Corp now owns 1,335 shares of the company’s stock valued at $138,000 after buying an additional 57 shares in the last quarter. Finally, Bartlett & Co. LLC increased its position in Monsanto by 10.6% in the second quarter. Bartlett & Co. LLC now owns 1,402 shares of the company’s stock valued at $145,000 after buying an additional 134 shares in the last quarter. 78.96% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Shares of Monsanto Co. (NYSE:MON) traded down 0.03% during midday trading on Friday, reaching $97.90. 3,138,504 shares of the company traded hands. Monsanto Co. has a 1-year low of $83.73 and a 1-year high of $114.26. The stock has a market capitalization of $42.88 billion, a P/E ratio of 32.76 and a beta of 1.01. The stock’s 50-day moving average is $101.48 and its 200-day moving average is $103.35.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. The company had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm’s revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.19) earnings per share. Equities analysts predict that Monsanto Co. will post $4.72 EPS for the current fiscal year.

Several research analysts recently commented on MON shares. Deutsche Bank AG raised their price target on shares of Monsanto from $118.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, September 15th. BMO Capital Markets set a $128.00 target price on shares of Monsanto and gave the company a “buy” rating in a research report on Thursday, September 15th. Monness Crespi & Hardt raised shares of Monsanto from a “neutral” rating to a “buy” rating and raised their target price for the company from $106.93 to $130.00 in a research report on Monday, August 8th. Jefferies Group reissued a “buy” rating on shares of Monsanto in a research report on Tuesday, September 6th. Finally, Piper Jaffray Cos. set a $128.00 target price on shares of Monsanto and gave the company a “buy” rating in a research report on Thursday, September 15th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. Monsanto presently has a consensus rating of “Buy” and a consensus price target of $114.65.

In other Monsanto news, Director Charles S. Mcmillan bought 3,500 shares of the stock in a transaction dated Monday, October 10th. The shares were acquired at an average cost of $103.23 per share, for a total transaction of $361,305.00. Following the completion of the transaction, the director now owns 64,009 shares in the company, valued at approximately $6,607,649.07. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert T. Fraley sold 80,631 shares of the firm’s stock in a transaction that occurred on Friday, October 14th. The stock was sold at an average price of $102.04, for a total transaction of $8,227,587.24. Following the transaction, the executive vice president now owns 38,711 shares in the company, valued at $3,950,070.44. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by company insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.